Cardiomyopathy

Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Group Medical Visits in Heart Failure

Condition:   Heart Failure
Intervention:   Behavioral: Group medical visits
Sponsor:   Department of Veterans Affairs
Recruiting - verified June 2015

A Trial of Autologous Bone Marrow Derived Stem Cells in Paediatric Heart Failure

Condition:   Dilated Cardiomyopathy
Intervention:   Biological: stem cell injection
Sponsor:   Great Ormond Street Hospital for Children NHS Foundation Trust
Completed - verified June 2015

Single Ascending Dose Study of MYK-461 in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Placebo;   Drug: MYK-461
Sponsor:   MyoKardia, Inc.
Recruiting - verified February 2015

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Drug: MYK-461
Sponsor:   MyoKardia, Inc.
Recruiting - verified June 2015

Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)

Conditions:   Dilated Cardiomyopathy (DCM);   Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy;   Heart Failure
Intervention:   Biological: Allogeneic Cardiosphere-Derived Cells (CDCs)
Sponsors:   Capricor Inc.;   Cedars-Sinai Medical Center;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified January 2015

Right Ventricle (RV) Markers of Future Pacing Induced Ventricular Dysfunction - Pilot

Condition:   Sick Sinus Syndrome
Intervention:  
Sponsors:   Basildon and Thurrock University Hospitals NHS Foundation Trust;   Anglia Ruskin University
Recruiting - verified June 2015

German Centre for Cardiovascular Research Cardiomyopathy Register

Condition:   Acute Myocarditis
Intervention:  
Sponsors:   Heidelberg University;   Bad Nauheim Heart Center;   Charite University, Berlin, Germany;   Goethe University;   University Hospital Goettingen;   University of Hamburg;   University of Kiel;   University of Luebeck;   Klinikum Ludwigshafen;   Mainz University;   Universitätsmedizin Mannheim;   University of München;   Medical University of Hannover;   University of Homburg;   Philipps University Marburg Medical Center;   University Hospital Muenster;   University Hospital Tuebingen;   Humboldt-Universität zu Berlin
Recruiting - verified June 2015

Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.

Conditions:   Heart Failure;   Cardiomyopathy;   Cardiac Arrhythmia
Intervention:   Procedure: QLV interval measurement
Sponsors:   University of California, San Diego;   Boston Scientific Corporation
Active, not recruiting - verified June 2015

Thoratec Corporation HeartMate III™ CE Mark Clinical Investigation Plan

Condition:   Advanced Refractory Left Ventricular Heart Failure
Intervention:   Device: Left Ventricular Assist System (LVAS)
Sponsors:   Thoratec Corporation;   Center for Life Sciences (C3TK);   Emergo Group;   Krakow Cardiovascular Research Institute
Active, not recruiting - verified June 2015

Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation

Conditions:   Cardiomyopathy;   Heart Failure;   Cardiac Arrhythmia
Interventions:   Device: Standard Defibrillation Testing;   Device: Upper Limit of Vulnerability Testing
Sponsors:   University of California, San Diego;   Medtronic
Completed - verified June 2015

RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators

Conditions:   Cardiomyopathy;   Cardiac Arrhythmia;   Heart Failure;   Chronic Thromboembolic Pulmonary Hypertension
Intervention:   Device: RF Assure Scanning
Sponsors:   University of California, San Diego;   RF Surgical Systems, Inc.
Completed - verified June 2015

Utilising Lifemap to Investigate Malignant Arrhythmia Therapy

Conditions:   Ischemic Cardiomyopathy;   Sudden Cardiac Death;   Implantable Defibrillator User;   Myocardial Infarction;   Arrhythmias, Cardiac
Intervention:  
Sponsors:   University Hospitals, Leicester;   University of Leicester
Recruiting - verified June 2015

Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Dilated Cardiomyopathy and Heart Failure.

Condition:   Idiopathic Dilated Cardiomyopathy
Interventions:   Drug: Infusion of autologous mononuclear bone marrow cells;   Drug: Placebo infusion
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas 
Recruiting - verified June 2015

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Other: None - this is an observational study
Sponsors:   University of Virginia;   National Heart, Lung, and Blood Institute (NHLBI);   Oxford University Hospitals NHS Trust
Recruiting - verified June 2015

Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients - TRICHAMPION STUDY

Condition:   Hypertrophic Cardiomyopathy With Obstruction
Intervention:   Device: CRT-P Implant
Sponsor:   St. Jude Medical
Recruiting - verified June 2015

Polypharmacy in the Heart Failure Patient: Are All Prescribed Drug Classes Required? Statin Withdrawal Study

Condition:   Heart Failure
Interventions:   Drug: Withdrawal of statin therapy;   Drug: Statin therapy
Sponsor:   The Alfred
Completed - verified June 2015

Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study

Condition:   Heart Failure
Interventions:   Drug: Aspirin;   Other: withdrawal of aspirin
Sponsor:   The Alfred
Completed - verified June 2015

A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure

Conditions:   Heart Failure;   Dilated Cardiomyopathy
Interventions:   Device: Algisyl-LVR;   Drug: Standard medical therapy
Sponsor:   LoneStar Heart, Inc.
Active, not recruiting - verified June 2015

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Conditions:   Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention:   Other: None. Observational Study.
Sponsor:   Pfizer
Recruiting - verified June 2015

Get CardioSmart

You're Invited